文献速递产科生殖医学

多囊卵巢综合征与不良妊娠结局风险:马萨诸塞州登记链接研究

Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
PubMed 文献 · Hum Reprod · 2022-01-01

该研究链接马萨诸塞州2013-2017年分娩记录与辅助生殖技术及保险索赔数据库,分析91 825次分娩中3.9%有多囊卵巢综合征(PCOS)病史者的妊娠结局。结果显示PCOS病史与妊娠期糖尿病、子痫前期、早产及分娩住院延长风险升高相关。

要点

  • PCOS病史者妊娠期糖尿病风险增加51%(CI:1.38-1.65)。
  • PCOS病史者子痫前期风险增加25%(CI:1.15-1.35)。
  • PCOS病史者早产风险RR 1.17(CI:1.06-1.29),分娩住院延长RR 1.23(CI:1.09-1.40)。

核心结论

  • 有PCOS病史的女性妊娠期糖尿病、子痫前期、早产及分娩住院延长风险更高。
  • 作者认为产科医生应了解患者PCOS状态并密切监测潜在妊娠并发症。

研究设计与样本

  • 观察性登记链接研究,链接马萨诸塞州2013-2017年≥18岁女性分娩生命记录与医院出院、观察停留及急诊就诊数据至SART CORS和Massachusetts APCD。
  • 共纳入91 825次分娩,其中3.9%有PCOS病史。
  • PCOS通过分娩前APCD中的ICD9和ICD10编码识别。

主要发现

  • PCOS病史者妊娠期糖尿病风险增加51%(CI:1.38-1.65)。
  • PCOS病史者子痫前期风险增加25%(CI:1.15-1.35)。
  • PCOS病史者早产风险RR 1.17(CI:1.06-1.29)。
  • PCOS病史者分娩住院延长风险RR 1.23(CI:1.09-1.40),额外调整孕龄后。
  • 孕前BMI<30 kg/m2的PCOS女性妊娠期糖尿病风险更高。

关键数值与推荐

  • 采用广义估计方程(对数链接、泊松分布)计算RR和95%CI,考虑多次周期。
  • 先验调整母亲年龄、BMI、种族/民族、教育、多胎、出生年份、慢性高血压和慢性糖尿病。
  • 同质性检验比较孕前BMI类别(<30、≥30、<25和≥25 kg/m2)及非不孕分娩与ART或亚不孕分娩。

临床怎么用

  • 作者建议产科医生应了解患者PCOS状态并密切监测潜在妊娠并发症,以改善母婴围产期健康结局。

局限性

  • PCOS通过分娩前ICD文档定义,未暴露组可能包含未诊断或分娩后诊断的PCOS女性。
  • 研究人群限于马萨诸塞州内大多数私人保险支付者的分娩及随访窗口内的住院或观察住院,州外或样本外诊断和/或分娩可能未被捕获。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have a greater risk of adverse pregnancy complications (gestational diabetes, preeclampsia, cesarean section, placental abnormalities) and neonatal outcomes (preterm birth, small for gestational age, prolonged delivery hospitalization) compared to women without a PCOS diagnosis and does this risk vary by BMI, subfertility and fertility treatment utilization? SUMMARY ANSWER: Deliveries to women with a history of PCOS were at greater risk of complications associated with cardiometabolic function, including gestational diabetes and preeclampsia, as well as preterm birth and prolonged length of delivery hospitalization. WHAT IS KNOWN ALREADY: Prior research has suggested that women with PCOS may be at increased risk of adverse pregnancy outcomes. However, findings have been inconsistent possibly due to lack of consistent adjustment for confounding factors, small samples size and other sources of bias. STUDY DESIGN, SIZE, DURATION: Massachusetts deliveries among women ≥18 years old during 2013-2017 from state vital records linked to hospital discharges, observational stays and emergency department visits were linked to the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) and the Massachusetts All-Payers Claims Database (APCD). PARTICIPANTS/MATERIALS, SETTING, METHODS: PCOS was identified by ICD9 and ICD10 codes in APCD prior to index delivery. Relative risks (RRs) and 95% CI for pregnancy and delivery complications were modeled using generalized estimating equations with a log link and a Poisson distribution to take multiple cycles into account and were adjusted a priori for maternal age, BMI, race/ethnicity, education, plurality, birth year, chronic hypertension and chronic diabetes. Tests for homogeneity investigated differences between maternal pre-pregnancy BMI categories (<30, ≥30, <25 and ≥25 kg/m2) and between non-infertile deliveries and deliveries that used ART or had a history of subfertility (defined by birth certificates, SART CORS records, APCD or hospital records). MAIN RESULTS AND THE ROLE OF CHANCE: Among 91 825 deliveries, 3.9% had a history of PCOS. Women with a history of PCOS had a 51% greater risk of gestational diabetes (CI: 1.38-1.65) and a 25% greater risk of preeclampsia (CI: 1.15-1.35) compared to women without a diagnosis of PCOS. Neonates born to women with a history of PCOS were more likely to be born preterm (RR: 1.17, CI: 1.06-1.29) and more likely to have a prolonged delivery hospitalization after additionally adjusting for gestational age (RR: 1.23, CI: 1.09-1.40) compared to those of women without a diagnosis of PCOS. The risk for gestational diabetes for women with PCOS was greater among women with a pre-pregnancy BMI <30 kg/m2. LIMITATIONS, REASONS FOR CAUTION: PCOS was defined by ICD documentation prior to delivery so there may be women with undiagnosed PCOS or PCOS diagnosed after delivery included in the unexposed group. The study population is limited to deliveries within Massachusetts among most private insurance payers and inpatient or observational hospitalization in Massachusetts during the follow-up window, therefore there may be diagnoses and or deliveries outside of the state or outside of our sample that were not captured. WIDER IMPLICATIONS OF THE FINDINGS: In this population-based study, women with a history of PCOS were at greater risk of pregnancy complications associated with cardiometabolic function and preterm birth. Obstetricians should be aware of patients' PCOS status and closely monitor for potential pregnancy complications to improve maternal and infant perinatal health outcomes. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the NIH (R01HD067270). S.A.M. receives grant funding from NIH, AbbVie and the Marriot Family Foundation; payment/honoraria from the University of British Columbia, World Endometriosis Research Foundation and Huilun Shanghai; travel support for attending meetings for ESHRE 2019, IASP 2019, National Endometriosis Network UK meeting 2019; SRI 2022, ESHRE 2022; participates on the data safety monitoring board/advisory board for AbbVie, Roche, Frontiers in Reproductive Health; and has a leadership role in the Society for Women's Health Research, World Endometriosis Research Foundation, World Endometriosis Society, American Society for Reproductive Medicine and ESHRE. The other authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Farland LV, Stern JE, Liu CL, et al. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum Reprod. 2022. PMID: 36149255. doi:10.1093/humrep/deac210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。